These results appear in line with the half-life of platelets, and suggest that in case of mandatory aspirin discontinuation for highly invasive interventions in patients at high risk of bleeding, the drug should be resumed well before that 8-10 days have
These results appear in line with the half-life of platelets, and suggest that in case of mandatory aspirin discontinuation for highly invasive interventions in patients at high risk of bleeding, the drug should be resumed well before that 8-10 days have
研究者称：“这些结果看起来与血小板的半衰期一致，表明在出血高危患者行大型侵入治疗而必须中断阿司匹林的情况下，应该在8～10天之内重新开始恰当地服用阿司匹林。